Ginkgo Bioworks Debuts 'Cloud Lab' Service
Ginkgo Bioworks has launched Cloud Lab, a service offering certified protocols for biological experiments. The platform aims to ease the high costs and complexity of setting up a physical laboratory by providing remote, automated lab services.
The Cloud Lab service is a key part of Ginkgo's 2026 strategic shift to move all R&D services to its autonomous lab in Boston, named Nebula. The goal is to systematically decommission traditional lab benches in favor of programmable, robotic infrastructure. Underpinning the service are proprietary Reconfigurable Automation Carts (RACs). These modular units combine high-precision robotic arms, maglev sample transport, and industrial-grade software, allowing for flexible and scalable automation that can be reconfigured for different workflows. This modular "building-block" approach is designed to avoid the bottlenecks of single-robot systems. A key feature of the platform is an AI-driven agent named EstiMate, which allows scientists to submit protocols in natural language. The system then provides an immediate assessment of its compatibility with the lab's autonomous fleet and generates a price quote, a process Ginkgo describes as unprecedented. Ginkgo's value proposition centers on accelerating R&D timelines and shifting capital expenditure to a variable cost structure for its clients. In a collaboration with OpenAI, Ginkgo demonstrated that its autonomous lab, driven by GPT-5, could reduce the cost of cell-free protein synthesis by 40% compared to state-of-the-art methods, executing 36,000 experiments in six months. This move into lab-as-a-service pits Ginkgo against other established players in the remote-controlled lab space, such as Strateos and Emerald Cloud Lab. Strateos, formerly Transcriptic, has a history of collaboration with Ginkgo and works with major pharmaceutical companies like Eli Lilly. The broader trend towards lab automation is driven by the need for higher throughput, increased reproducibility, and reduced errors. The market for virtual and remote laboratories was valued at approximately $1.45 billion in 2025 and is projected to grow, spurred by the increasing adoption of e-learning and the need for scalable lab infrastructure. CEO Jason Kelly has stated the company is "investing to win" in the autonomous labs category. The strategy involves not only offering cloud access but also building entire autonomous labs for customers, targeting national labs, biopharma, and research universities. This follows years of developing and battle-testing the automation systems internally with Ginkgo's own scientists.
